WST
West Pharmaceutical Services Inc
NYSE: WST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$403.64
+1.34% today
Updated 2026-10-28
Market cap
$28.03B
P/E ratio
51.00
P/S ratio
8.43x
EPS (TTM)
$7.81
Dividend yield
0.22%
52W range
$224 – $405
Volume
0.6M
West Pharmaceutical Services Inc (WST) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$403.64
12-Month target
$203.74
2030 Target
—
Intrinsic (DCF)
$171.03
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.9B | $3.0B | $2.9B | $3.1B | $3.3B | $3.5B | $3.8B | $4.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 7.44% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 17.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.